Whole-body hyperthermia as a novel antidepressant therapy

First-line treatments for major depressive disorder include medication and cognitive behavioral therapy. While effective, pharmacotherapy often takes time to start demonstrating efficacy in symptomatic improvement and may be accompanied by adverse effects, indicating an ongoing need for new therapeutic approaches. A recently emerging somatic antidepressant intervention is whole-body hyperthermia, in which subjects are temporarily exposed to heat and then allowed to cool down. Recent studies employing hyperthermia-based strategies appear to show mood improvements both immediately and several weeks after the conclusion of treatment. However, published studies are often limited by their sample sizes and by their selection criteria. In this article, we review the literature on this novel approach and propose ideas regarding the possible physiological basis of this novel intervention and how it may be used in the future as adjunctive therapy with the current standard of care. • We review recent advances in whole-body hyperthermia treatments for major depressive disorder. • Studies have shown immediate and persistent improvements in mood symptoms. • Studies are often limited by small sample sizes and selection criteria for subjects.

Authors

Institutions

Publication Details

Journal
Biomarkers in Neuropsychiatry
Published
2025-03-04
DOI
https://doi.org/10.1016/j.bionps.2025.100124
Primary Topic
Tryptophan and brain disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Whole-body hyperthermia as a novel antidepressant therapy

Kevin D. Gaitonde, Henry A. Nasrallah
Biomarkers in Neuropsychiatry
Tryptophan and brain disorders
article

Whole-body hyperthermia as a novel antidepressant therapy

Kevin D. Gaitonde, Henry A. Nasrallah
article en

Abstract

First-line treatments for major depressive disorder include medication and cognitive behavioral therapy. While effective, pharmacotherapy often takes time to start demonstrating efficacy in symptomatic improvement and may be accompanied by adverse effects, indicating an ongoing need for new therapeutic approaches. A recently emerging somatic antidepressant intervention is whole-body hyperthermia, in which subjects are temporarily exposed to heat and then allowed to cool down. Recent studies employing hyperthermia-based strategies appear to show mood improvements both immediately and several weeks after the conclusion of treatment. However, published studies are often limited by their sample sizes and by their selection criteria. In this article, we review the literature on this novel approach and propose ideas regarding the possible physiological basis of this novel intervention and how it may be used in the future as adjunctive therapy with the current standard of care. • We review recent advances in whole-body hyperthermia treatments for major depressive disorder. • Studies have shown immediate and persistent improvements in mood symptoms. • Studies are often limited by small sample sizes and selection criteria for subjects.

Biomarkers in NeuropsychiatryVol. 12
University of Cincinnati (US), University of Cincinnati Medical Center (US)
Openalex Percentile: Top 96%
Tryptophan and brain disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.